Type 2 Diabetes
(Diabetes Mellitus Type 2; Insulin-Resistant Diabetes; Diabetes, Type 2)En Español (Spanish Version)More InDepth Information on This Condition
Diabetes is a higher level of glucose in the blood than is normal. Glucose comes from the breakdown of the food you eat. It travels through your body in the blood. A hormone called insulin then helps glucose move from your blood to your cells. Once glucose is in your cells it can be used for energy. A problem making or using insulin means glucose can not move into your cells. Instead the glucose will build up in your blood.
In type 2 diabetes, the body is resistant to high levels of insulin. This means there is plenty of insulin in the body, but the cells are unable to use it. This will lead to the build up of glucose in the blood, also called hyperglycemia. At the same time, your cells are not getting glucose they need to function well. Over a long period of time high blood glucose levels can damage vital organs. The kidneys, eyes, and nerves are most commonly affected organs.
Copyright © Nucleus Medical Media, Inc.
Two conditions contribute to hyperglycemia in type 2 diabetes:
- Insulin resistance related to excess body fat
- Body's failure to make an adequate amount of insulin
Factors that increase your chance for type 2 diabetes include:
- Having a family history of type 2 diabetes
- Being obese or overweight, especially excess weight in the upper body and abdomen
- Eating a lot of meat, especially processed meat (eg, processed luncheon meats, hot dogs, sausages)
- Having cholesterol problems especially low HDL (good) cholesterol and high triglycerides
- Having high blood pressure
- Having a history of cardiovascular disease
- Having depression
- Having a history of gestational diabetes or having a baby that weighs over nine pounds
- Having an endocrine disorder (eg, Cushing’s syndrome , hyperthyroidism , acromegaly , polycystic ovary syndrome , pheochromocytoma, glucagonoma)
- Having a condition associated with insulin resistance (eg, acanthosis nigricans )
- Having previous blood test results that show impaired glucose tolerance and impaired fasting glucose
- Taking certain medicines (eg, pentamidine , nicotinic acid, glucocorticoids, thiazides)
- Having a sedentary lifestyle
- Having sleep difficulties
- Having a low birth weight
- Gender: more common in older women than men
- Race: African American, Hispanic, Native American, Hispanic American, Asian American, or Pacific Islander
- Age: 45 years or older and younger people who are obese and belong to at risk ethnic groups
You may have diabetes for years before you have symptoms you notice. Symptoms due to high blood sugar or diabetic complications may include:
- Increased urination
- Extreme thirst
- Blurry vision
- Frequent or recurring infections
- Poor wound healing
- Painful leg cramps when walking
- Numbness or tingling in the hands or feet
- In women: frequent vaginal yeast infections and urinary tract infections
- Problems with gums
The doctor will ask about your symptoms and medical history. You will also be asked about your family history. A physical exam will be done.
Diagnosis is based on the results of blood testing. American Diabetes Association (ADA) guidelines for diagnosis include:
- Symptoms of diabetes and a random blood test with a blood sugar level greater than or equal to 200 mg/dL [11.1 mmol/L]
- Fasting blood sugar test —done after you have not eaten for eight or more hours — showing blood sugar levels greater than or equal to 126 mg/dL (7.0 mmol/L) on two different days
- Glucose tolerance test — measuring blood sugar two hours after you consume glucose — showing glucose levels greater than or equal to 200 mg/dL (11.1 mmol/L)
- HbA1c level of 6.5% or higher — indicates poor blood sugar control over the past 2-4 months
mg/dL=milligrams per deciliter of blood; mmol/L=millimole per liter of blood
Treatment aims to:
- Maintain blood sugar at levels as close to normal as possible
- Preventing or delaying complications (regular medical care is important for this)
- Control other conditions that you may have, like high blood pressure and high cholesterol
- Follow a balanced meal plan. Practice good portion control.
- Do not skip meals. Plan your meals and snacks through the day. Having meals regularly throughout the day can help maintain blood glucose.
- Eat plenty of vegetables and fiber .
- Eat limited amounts of fat .
- Eat moderate amounts of protein and low-fat dairy products .
- Carefully limit foods containing high concentrated sugar .
- Keep a record of your food intake. This will help a dietitian or doctor advise you.
If you are overweight, talk to your doctor about a healthy weight goal. Your body will respond better to insulin after weight loss. You and your doctor or nutritionist can develop a safe nutrition plan for you.
These options may help you lose weight:
- Using a portion control plate BE
- Using a prepared meal plan
- Consider using a Mediterranean-style diet
Group education may help you with your weight loss goals.
Physical activity plays an important role in blood glucose control. Activity can
- Make the body more sensitive to insulin
- Help you reach and maintain a healthy weight
- Lower the levels of fat in your blood
Talk to your doctor about an activity plan and any precautions you should take.
Certain medicine will help you manage your blood glucose.
Your doctor may recommend medicine taken by mouth such as:
- Metformin — help to reduces the amount of glucose made by the body and also makes the body more sensitive to insulin
Drugs that prompt the pancreas to make more insulin (eg, sulfonylureas [
], dipeptidyl peptidase-4 inhibitors [
[Prandin], linagliptin [Tradjenta])
- The FDA has warned that sitagliptin may increase the risk of acute pancreatitis.
- Insulin sensitizers—help the body better use insulin such as, pioglitazone
- Starch blockers—decrease the amount of glucose absorbed into the blood such as acarbose or miglitol )
Some medicine needs to be given through injections such as:
For some, the body does not make enough insulin. Insulin injections may be needed. It may be used if blood sugar levels can not be controlled with lifestyle change and medicine.
Blood Sugar Testing
Checking blood sugar levels during the day can help you stay on track. It will also helps your doctor determine if your treatment is working. Testing is easy with a monitor. Keeping track of blood sugar levels is especially important if you take insulin. Frequency of testing is determined by how well your blood sugar control is doing.
The HbA1c may also be done at your doctor's office. Doctors advise that most keep their HbA1c levels below 7% (ADA recommendation). This level has been shown to lead to fewer diabetic complications.
Regular blood sugar testing may not be needed in patients with type 2 diabetes. It may not be needed for those whose condition is under reasonably good control without insulin. Talk with your doctor before stopping blood sugar monitoring.
One study focused on people with a specific type 2 diabetes. When given vitamin E, they showed a decrease in the rates of heart problems.
Lifestyle changes seem to be most effective. To reduce your chances of developing type 2 diabetes:
- Participate in regular physical activity.
- Maintain a healthy weight.
- Drink alcohol in moderation (two drinks per day for a man, and one drink per day for a woman)
Eat a well-balanced diet:
- Get enough fiber
- Avoid fatty foods
- Limit sugar intake
- Eat more green, leafy vegetables
American Diabetes Association
National Diabetes Information Clearinghouse
Canadian Diabetes Association
Team Diabetes Canada
Canadian Diabetes Association
American Association of Clinical Endocrinologists, American College of Endocrinology. Medical guidelines for the management of diabetes mellitus. The AACe system of intensive diabetes self-management. 2002 update. Endocrine Practice . 2002;8(suppl 1):S40-82.
American Diabetes Association Diagnosis and Classification of Diabetes Mellitus. Diabetes Care . 2010;33:S62-S69.
Boren SA, Gunlock TL, Schaefer J, Albright A. Reducing risks in diabetes self-management: a systematic review of the literature. Diabetes Educ . 2007;33:1053-1077.
Calvagna M. Tips to help you stop smoking. EBSCO Health Library website. Available at: http://www.ebscohost.com/healthLibrary/ . Updated January 2006. Accessed July 7, 2008.
Diabetes. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/nccdphp/publications/aag/ddt.htm . Updated February 14, 2008. Accessed July 21, 2008.
Diabetes. National Institute of Diabetes and Digestive and Kidney Diseases website. Available at: http://diabetes.niddk.nih.gov/ . Accessed July 22, 2008.
Diabetes mellitus type 2. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated June 19, 2012. Accessed June 21, 2012.
Diagnosis and classification of diabetes mellitus. Diabetes Care . 2005;28(suppl 1):S37-42.
Dietary considerations for patients with type 2 diabetes. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated January 26, 2011. Accessed March 10, 2011.
FDA approves new drug treatment for type 2 diabetes. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm174780.htm . Published July 31, 2009. Accessed October 1, 2009.
Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med . 2003; 248:383-393.
Harsch IA. Inhaled insulins: their potential in the treatment of diabetes mellitus. Treat Endocrinol . 2005;4:131-138.
Information about acarbose (Precose). The Diabetes Monitor website. Available at: http://www.diabetesmonitor.com/acarbose.htm . Accessed on May 26, 2006.
Juan D. Lifestyle changes to manage type 2 diabetes. EBSCO Health Library website. Available at: http://www.ebscohost.com/healthLibrary/ . Updated July 2007. Accessed July 7, 2008.
Lee DC, Sui X, Church TS, Lee IM, Blair SN. Associations of cardiorespiratory fitness and obesity with risks of impaired fasting glucose and type 2 diabetes in men. Diabetes Care. 2009;32:257-262. Epub 2008 Nov 4.
Marre M. Reducing cardiovascular risk in diabetes. J Hypertens . 2007;(supp 11)S19-22.
Physical activity/exercise and diabetes. Diabetes Care . 2004;27(suppl 1):S58-62.
Rosenbloom AL, Silverstein JH, Amemiya S, et al. ISPAD Clinical Practice Consensus Guideline 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes. 2008;9:512-526.
Rosenzweig JL, Ferrannini E, Grundy SM, et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at meta2bolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3671-3689.
Screening for type 2 diabetes. Diabetes Care . 2004;27(suppl 1):S11-4.
Sitagliptin (marketed as Januvia and Janumet)—acute pancreatitis. US Food and Drug Administration website. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm . Published September 25, 2009. Accessed October 29, 2009.
Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE and VA diabetes trials: a position statement of the American Diabetes association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009;119:351-7.
Standards of medical care in diabetes—2009. Diabetes Care. 2009;32:S13-61.
Statement by an AACE/ACE Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control. Endocr Pract . 2009;15:540-559.
Traina AN, Kane MP. Primer on pramlintide, an amylin analog. Diabetes Educ. 2011;37(3):426-431.
Type 2 diabetes. American Diabetes Association website. Available at: http://www.diabetes.org/type-2-diabetes.jsp . AccessedNov 13, 2009.
UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet . 1998; 352:954-965.
US Preventive Services Task Force: Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148:846-54.
US Preventive Services Task Force (USPSTF). Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med . 2003; 138:212-214.
11/29/2006 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet . 2006;368:1673-1679.
9/19/2006 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews . 2006;CD002968.
6/1/2007 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med . 2007 May 21. [Epub ahead of print]
7/13/2007 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Farmer A, Wade A, Goyder E, et al. Impact of self-monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ . 2007 Jun 25. [Epub ahead of print]
12/13/2007 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Milman U, Blum S, Shapira C, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype. A prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol . 2007 Nov 21. [Epub ahead of print]
2/13/2008 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease. NIH News. National Institutes of Health website. Available at: http://www.nih.gov/news/health/feb2008/nhlbi-06.htm . Accessed February 13, 2008.
2/21/2008 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Major international diabetes study does not confirm increased risk of death reported by US trial. Action in Diabetes and Vascular Disease: PreteraAx and DiamicroN MR Controlled Evaluation (ADVANCE) website. Available at: http://www.advance-trial.com/static/html/virtual/contents.asp?P=39 . Accessed February 21, 2008.
2/28/2008 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Davies MJ, Heller S, Skinner TC, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ . 2008 Feb 14. [Epub ahead of print]
2/28/2008 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, Bock BC. Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight. Arch Intern Med . 2008;168:141-146.
6/18/2008 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med . 2008;358:2560-2572. Epub 2008 Jun 6.
2/24/2009 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Liese AD, Weis KE, Schulz M, Tooze JA. Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2009;32:263-268. Epub 2008 Nov 25.
5/11/2009 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Loimaala A, Groundstroem K, Rinne M, et al. Effect of long-term endurance and strength training on meta2bolic control and arterial elasticity in patients with type 2 diabetes mellitus. Am J Cardiol. 2009;103:972-977.
8/19/2009 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Li TY, Brennan AM, Wedick NM, Mantzoros C, Rifai N, Hu FB. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr. 2009;139:1333-1338.
10/12/2009 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Crandall JP, Polsky S, Howard AA, et al. Alcohol consumption and diabetes risk in the Diabetes Prevention Program. Am J Clin Nutr. 2009;90:595-601.
11/20/2009 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Lund SS, Tarnow L, Frandsen M, et al. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. BMJ. 2009;339:b4324.
12/21/2009 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta2-analysis. Diabetes Care. 2009 Nov 12.
2/15/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(suppl 1:S11-61).
2/15/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1:S62-69).
7/2/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta2-analysis. Circulation. 2010;121(21):2271-2283.
10/5/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta2-analysis. BMJ. 2010;341:c4229.
1/4/2011 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Pan A, Lucas M, Sun Q, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010;170(21):1884-1891.
5/6/2011 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : US Food and Drug Administration. FDA approves new treatment for Type 2 diabetes. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm253501.htm . Updated May 2, 2011. Accessed May 6, 2011.
Last reviewed September 2011 by Lawrence Frisch, MD, MPH
Last updated Updated: 7/17/2012
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2010 EBSCO Publishing All rights reserved.